FDA Approved: CELLCEPT — Supplemental Application (Genentech, Inc.)

View source ↗

Summary

FDA approved a supplemental application for CellCept to update labeling, expanding its use for prevention of organ transplant rejection in recipients of kidney,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Transplantation
• Kidney Transplantation
• Liver Transplantation

Drugs mentioned

• CELLCEPT (mycophenolate mofetil hydrochloride)

Snippet

SUPPL AP for CELLCEPT (MYCOPHENOLATE MOFETIL HYDROCHLORIDE)